Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

UK-5099

SKU: orb1302857

Description

UK-5099 (PF-1005023) is a cell-permeable inhibitor that selectively and reversibly targets the mitochondrial pyruvate carrier (MPC) at the MPC2 subunit, blocking pyruvate import into mitochondria. Its ability to modulate pyruvate metabolism has established its utility as a research tool in oncology, with demonstrated antitumor effects in both cellular and animal models of cancer.

Research Area

Cancer Biology, Neuroscience, Stem Cell & Developmental Biology

Images & Validation

Key Properties

CAS Number56396-35-1
MW288.30
Purity>98%
FormulaC18H12N2O2
SMILESOC(=O)C(=Cc1cn(-c2ccccc2)c2ccccc12)C#N
TargetMitochondrial Metabolism
SolubilitySoluble in DMSO (up to 30 mg/ml) or in Ethanol (up to 8 mg/ml)

Bioactivity

Target IC50
MPC:50 nM
In Vivo
UK5099 increases the glucose excursion seen during an intraperitoneal glucose tolerance test in C57BLK mice.
In Vitro
The trypanosomal pyruvate carrier is found to be rather insensitive to inhibition by alpha-cyano-4-hydroxycinnamate (Ki: 17 mM) but can be completely blocked by UK-5099 (Ki: 49 μM). UK-5099 also inhibits the monocarboxylate transporter (MCT) . UK5099 dose-dependently significantly inhibits the glucose-stimulated rise in oxygen consumption and at 150 μM reduced oxygen consumption below basal levels. UK5099 reduces ATP levels and increases ADP and AMP levels in 832/13 cells. The UK5099 treated cells show a significantly higher proportion of side population fraction and express higher levels of stemness markers Oct3/4 and Nanog. The UK5099 application may be an ideal model for Warburg effect studies.
Cell Research
The 832/13 cell line derived from INS-1 rat insulinoma cells is used for experiments. Cell viability is measured using CellTiter Blue. The assay is based on the cellular reduction of resazurin to resorufin. The appearance of resorufin is monitored by fluorescence emission at 585 nm using a Spectramax M5 microplate reader with excitation at 555 nm. For UK5099-treated cells, cells are allowed to recover for 1 h before measuring cell viability. Data are expressed as -fold relative to no treatment or siCtrl.
Animal Research
C57BLK mice are fasted for 16 h prior to glucose challenge. UK5099 (32 μmol/kg of body weight) or DMSO in PBS is injected into the intraperitoneal cavity 30 min before injecting glucose (1.5 mg of glucose/g of body weight). Blood glucose levels are measured at 0, 10, 20, 30, 60, and 120 min after glucose injection.

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

MPC, inhibit, Mitochondrial Metabolism, MitochondrialMetabolism, Inhibitor, UK5099, UK-5099, UK 5099, PF 1005023, PF1005023, PF-1005023

Similar Products

  • MPC-IN-1 [orb2663651]

    303.31

    C18H13N3O2

    50 mg, 10 mg
  • UK-5099 [orb1223096]

    >98% (HPLC)

    56396-35-1

    288.3

    C18H12N2O2

    2 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg, 500 mg, 1 g
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

5 mg
$ 200.00
25 mg
$ 450.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry